No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

in StudyGraphics

RELATED REPORTS

FDA grants priority review for iberdomide-based myeloma regimen

Replacing sedentary time with physical activity may lower risk of all-cause mortality

Metformin and ursodeoxycholic acid do not improve long COVID recovery

Dihydroartemisinin-piperaquine reduces children death or readmission with severe anemia

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026

Reduced gestational weight gain with lifestyle intervention

Cardiology

Replacing sedentary time with physical activity may lower risk of all-cause mortality

March 2, 2026

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Chronic Disease

Metformin and ursodeoxycholic acid do not improve long COVID recovery

March 2, 2026

AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

2 Minute Medicine Rewind Jan 25, 2021

Majority of obese tenth-graders already obese by fifth grade

Time restricted eating effective as a modest weight loss strategy for obese adults

Prescription of antibiotics for acute respiratory infections increasing

Tocilizumab not superior to standard care in randomized controlled trial for severe COVID-19 patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result